NL191508C - Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat. - Google Patents
Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat.Info
- Publication number
- NL191508C NL191508C NL8001721A NL8001721A NL191508C NL 191508 C NL191508 C NL 191508C NL 8001721 A NL8001721 A NL 8001721A NL 8001721 A NL8001721 A NL 8001721A NL 191508 C NL191508 C NL 191508C
- Authority
- NL
- Netherlands
- Prior art keywords
- glycinamide derivative
- preparation
- glycinamide
- pharmaceutical preparation
- preparation containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU81068A LU81068A1 (fr) | 1979-03-22 | 1979-03-22 | Derives de la glycinamide, leur preparation et utilisation, ainsi que compositions contenant ces derives |
LU81069A LU81069A1 (fr) | 1979-03-22 | 1979-03-22 | Derive de glycinamide, preparation de ce derive, son utilisation ainsi que composition contenant ce derive |
LU81069 | 1979-03-22 | ||
LU81068 | 1979-03-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
NL8001721A NL8001721A (nl) | 1980-09-24 |
NL191508B NL191508B (nl) | 1995-04-18 |
NL191508C true NL191508C (nl) | 1995-08-21 |
Family
ID=26640253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8001721A NL191508C (nl) | 1979-03-22 | 1980-03-24 | Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat. |
Country Status (18)
Country | Link |
---|---|
US (1) | US4639468A (nl) |
AT (1) | AT381302B (nl) |
AU (1) | AU536499B2 (nl) |
CA (1) | CA1184567A (nl) |
CH (1) | CH645091A5 (nl) |
DE (2) | DE3050800C2 (nl) |
DK (1) | DK162714C (nl) |
ES (1) | ES8104790A1 (nl) |
FI (1) | FI82033C (nl) |
FR (1) | FR2451913A1 (nl) |
GB (1) | GB2048852B (nl) |
GR (1) | GR68005B (nl) |
IE (1) | IE49751B1 (nl) |
IL (1) | IL59679A (nl) |
NL (1) | NL191508C (nl) |
NO (1) | NO157817C (nl) |
PT (1) | PT70992A (nl) |
SE (1) | SE453917B (nl) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2937698A1 (de) * | 1979-09-18 | 1981-04-02 | A. Nattermann & Cie GmbH, 5000 Köln | N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis |
DK373383A (da) * | 1982-08-20 | 1984-02-21 | Midit | Fremgangsmaade til fremstilling af omega-aminosyrederivater |
US4798687A (en) * | 1987-02-06 | 1989-01-17 | Pennwalt Corporation | 2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives |
US4904681A (en) * | 1987-12-01 | 1990-02-27 | G. D. Searle & Co. | D-cycloserine and its prodrugs as cognitive enhancers |
US4891058A (en) * | 1988-07-18 | 1990-01-02 | Ici Americas Inc. | 1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use |
US5278191A (en) * | 1988-08-31 | 1994-01-11 | G. D. Searle & Co. | Diphenylmethylaminoacetamide derivatives as anti-convulsants |
US5288905A (en) * | 1988-10-07 | 1994-02-22 | G. D. Searle & Co. | Glycyl urea derivatives as anti-convulsants |
US4944796A (en) * | 1988-11-14 | 1990-07-31 | Ici Americas Inc. | Certain 2-(disubstituted amino) acetanilide herbicides |
DE3915755A1 (de) * | 1989-05-13 | 1990-11-29 | Bayer Ag | Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung |
IL94466A (en) * | 1989-05-25 | 1995-01-24 | Erba Carlo Spa | Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation |
US5075337A (en) * | 1989-07-26 | 1991-12-24 | G. D. Searle & Co. | Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders |
US5153226A (en) * | 1989-08-31 | 1992-10-06 | Warner-Lambert Company | Acat inhibitors for treating hypocholesterolemia |
DE4102042A1 (de) * | 1991-01-24 | 1992-07-30 | Bayer Ag | Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide |
US5141960A (en) * | 1991-06-25 | 1992-08-25 | G. D. Searle & Co. | Tricyclic glycinamide derivatives as anti-convulsants |
GB9306899D0 (en) * | 1993-04-01 | 1993-05-26 | Erba Carlo Spa | Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation |
GB9306886D0 (en) * | 1993-04-01 | 1993-05-26 | Erba Carlo Spa | Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation |
US5585358A (en) * | 1993-07-06 | 1996-12-17 | Yissum Research Development Corporation Of The Hebrew University Of Jerusalem | Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents |
CN1327383A (zh) * | 1996-05-31 | 2001-12-19 | 阿列里克斯神经科学公司 | 治疗神经和神经精神障碍的药物 |
US6191165B1 (en) * | 1996-05-31 | 2001-02-20 | Allelix Neuroscience Inc. | Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
IT1283489B1 (it) * | 1996-07-23 | 1998-04-21 | Chiesi Farma Spa | Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico |
GB9727523D0 (en) | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Alpha-aminoamide derivatives useful as analgesic agents |
US6984754B1 (en) | 1998-03-26 | 2006-01-10 | University Of Saskatchewan Technologies Inc. | Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents |
ES2296383T3 (es) * | 1998-03-26 | 2008-04-16 | University Of Saskatchewan | Acidos aminofosfonicos y aminocarboxilicos alifaticos, aminonitrilos y aminotetrazoles como agentes de restablecimiento de las funciones celulares. |
US6346547B1 (en) * | 1999-02-08 | 2002-02-12 | Checkpoint, Genetics, Inc. | N-substituted amino acids, antioxidant pharmaceutical compositions containing n-substituted amino acids and methods for preventing cardiovascular diseases and/or preventing and/or treating antioxidant responsive diseases therewith |
NZ523917A (en) * | 2000-07-21 | 2004-11-26 | Teva Pharma | Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder |
HUP0401867A2 (hu) * | 2000-08-17 | 2004-12-28 | Teva Pharmaceutical Industries Ltd. | A valproinsav-amid és a 2-valproénsav-amid származékainak használata a fájdalommal és a fejfájással járó betegségek kezelésére vagy megelőzésére |
DE60134337D1 (de) * | 2000-11-21 | 2008-07-17 | Ucb Pharma Sa | N-alkylierte gaba verbindungen, verfahren zu deren |
BR0207307A (pt) | 2001-02-16 | 2004-08-17 | Allelix Neuroscience Inc | Inibidores de glyt-1 |
US20030035784A1 (en) * | 2001-03-05 | 2003-02-20 | Kao Corporation | Hair cosmetic, aminocarboxylic acid amide and method for producing the same |
BRPI0212298B8 (pt) | 2001-09-03 | 2021-05-25 | Newron Pharm Spa | composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico |
EP1438956A1 (en) * | 2003-01-16 | 2004-07-21 | Newron Pharmaceuticals S.p.A. | Alpha-aminoamide derivatives useful as antimigraine agents |
RS51411B (en) * | 2004-09-10 | 2011-02-28 | Newron Pharmaceuticals S.P.A. | USE (R) - (HALOBENZYLOXY) BENZYLAMINO-PROPANAMIDE AS SELECTIVE MODULATORS OF SODIUM AND / OR CALCIUM CHANNELS |
CN101018843B (zh) * | 2004-09-13 | 2011-05-11 | 西巴特殊化学品控股有限公司 | 烷基氨基乙酰胺润滑添加剂 |
FR2896991A1 (fr) * | 2006-02-03 | 2007-08-10 | Inst Nat Sante Rech Med | Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique |
CN102351733B (zh) * | 2011-07-21 | 2014-03-19 | 凯莱英医药化学(阜新)技术有限公司 | 一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法 |
SI3766916T1 (sl) | 2014-06-25 | 2023-01-31 | Acuitas Therapeutics Inc. | Formulacije novih lipidov in lipidnih nanodelcev za dostavo nukleinskih kislin |
JP6053724B2 (ja) * | 2014-06-26 | 2016-12-27 | 国立大学法人九州大学 | イオン交換樹脂及び金属の吸着分離方法 |
WO2017004143A1 (en) | 2015-06-29 | 2017-01-05 | Acuitas Therapeutics Inc. | Lipids and lipid nanoparticle formulations for delivery of nucleic acids |
EP4212510A1 (en) | 2015-10-28 | 2023-07-19 | Acuitas Therapeutics Inc. | Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids |
CN106187829B (zh) * | 2016-07-29 | 2017-12-15 | 万华化学集团股份有限公司 | 一种制备乙二胺基乙磺酸盐的方法 |
WO2018191657A1 (en) | 2017-04-13 | 2018-10-18 | Acuitas Therapeutics, Inc. | Lipids for delivery of active agents |
CA3061612A1 (en) | 2017-04-28 | 2018-11-01 | Acuitas Therapeutics, Inc. | Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids |
EP3668833A1 (en) | 2017-08-16 | 2020-06-24 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
US11524932B2 (en) | 2017-08-17 | 2022-12-13 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
US11542225B2 (en) | 2017-08-17 | 2023-01-03 | Acuitas Therapeutics, Inc. | Lipids for use in lipid nanoparticle formulations |
WO2019036000A1 (en) * | 2017-08-17 | 2019-02-21 | Acuitas Therapeutics, Inc. | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS |
KR101953366B1 (ko) | 2018-12-26 | 2019-02-28 | 정종문 | 침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법 |
WO2020146805A1 (en) | 2019-01-11 | 2020-07-16 | Acuitas Therapeutics, Inc. | Lipids for lipid nanoparticle delivery of active agents |
USD926577S1 (en) | 2019-09-23 | 2021-08-03 | Verdant Ventures | Tamper-resistant lid assembly |
US11326923B2 (en) | 2019-10-08 | 2022-05-10 | Verdant Ventures | Tamper-resistant lid assembly for dispensing a premeasured amount of liquid |
CA3189338A1 (en) | 2020-07-16 | 2022-01-20 | Acuitas Therapeutics, Inc. | Cationic lipids for use in lipid nanoparticles |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2368208A (en) * | 1940-12-16 | 1945-01-30 | Emulsol Corp | Chemical compounds and method of preparing same |
US2781385A (en) * | 1953-09-21 | 1957-02-12 | Gefgy Chemical Corp | Diamidocarboxylic acids and certain salts thereof |
LU43649A1 (nl) * | 1962-05-09 | 1963-07-16 | ||
JPS5319654B2 (nl) * | 1974-03-14 | 1978-06-22 | ||
DE2832009A1 (de) * | 1978-07-20 | 1980-01-31 | Deutsches Krebsforsch | Verwendung von sarkosin und sarkosinderivaten ls tumorhemmende wirksubstanzen |
-
1980
- 1980-03-20 DE DE3050800A patent/DE3050800C2/de not_active Expired
- 1980-03-20 DE DE19803010599 patent/DE3010599A1/de active Granted
- 1980-03-21 SE SE8002204A patent/SE453917B/sv not_active IP Right Cessation
- 1980-03-21 FR FR8006390A patent/FR2451913A1/fr active Granted
- 1980-03-21 NO NO800830A patent/NO157817C/no unknown
- 1980-03-21 ES ES490536A patent/ES8104790A1/es not_active Expired
- 1980-03-21 DK DK123580A patent/DK162714C/da not_active IP Right Cessation
- 1980-03-21 FI FI800900A patent/FI82033C/fi not_active IP Right Cessation
- 1980-03-21 CH CH225380A patent/CH645091A5/fr not_active IP Right Cessation
- 1980-03-21 PT PT70992A patent/PT70992A/pt active IP Right Revival
- 1980-03-21 IL IL59679A patent/IL59679A/xx unknown
- 1980-03-21 AT AT0154680A patent/AT381302B/de not_active IP Right Cessation
- 1980-03-22 GR GR61512A patent/GR68005B/el unknown
- 1980-03-24 IE IE599/80A patent/IE49751B1/en not_active IP Right Cessation
- 1980-03-24 NL NL8001721A patent/NL191508C/nl not_active IP Right Cessation
- 1980-03-24 CA CA000348319A patent/CA1184567A/en not_active Expired
- 1980-03-24 GB GB8009801A patent/GB2048852B/en not_active Expired
- 1980-03-24 AU AU56784/80A patent/AU536499B2/en not_active Expired
-
1985
- 1985-08-23 US US06/768,185 patent/US4639468A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NL191508B (nl) | 1995-04-18 |
ES490536A0 (es) | 1981-04-16 |
AU5678480A (en) | 1980-09-25 |
PT70992A (fr) | 1980-04-01 |
GR68005B (nl) | 1981-10-26 |
GB2048852A (en) | 1980-12-17 |
NO800830L (no) | 1980-09-23 |
FR2451913A1 (fr) | 1980-10-17 |
NO157817C (no) | 1988-05-25 |
ATA154680A (de) | 1986-02-15 |
NL8001721A (nl) | 1980-09-24 |
GB2048852B (en) | 1983-03-30 |
SE8002204L (sv) | 1980-09-23 |
FI800900A (fi) | 1980-09-23 |
IE49751B1 (en) | 1985-12-11 |
DE3010599A1 (de) | 1980-10-09 |
DE3050800C2 (nl) | 1989-06-22 |
DK162714B (da) | 1991-12-02 |
SE453917B (sv) | 1988-03-14 |
FR2451913B1 (nl) | 1984-07-13 |
AT381302B (de) | 1986-09-25 |
DK123580A (da) | 1980-09-23 |
IE800599L (en) | 1980-09-22 |
NO157817B (no) | 1988-02-15 |
DK162714C (da) | 1992-04-21 |
AU536499B2 (en) | 1984-05-10 |
US4639468A (en) | 1987-01-27 |
FI82033B (fi) | 1990-09-28 |
IL59679A (en) | 1984-11-30 |
DE3010599C2 (nl) | 1989-03-02 |
FI82033C (fi) | 1991-01-10 |
IL59679A0 (en) | 1980-06-30 |
CH645091A5 (fr) | 1984-09-14 |
CA1184567A (en) | 1985-03-26 |
ES8104790A1 (es) | 1981-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL191508C (nl) | Farmaceutisch preparaat, dat tenminste één glycinamidederivaat bevat, alsmede glycinamide derivaat, dat geschikt is voor gebruik in een zodanig preparaat. | |
NO801863L (no) | Farmasoeytiske preparater. | |
NL191738C (nl) | ML-236B-derivaten, werkwijze voor hun bereiding en farmaceutische preparaten, die deze derivaten bevatten. | |
NL190552B (nl) | 1-fenyl-4-alkyl-7,8-dialkoxy-5h-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten. | |
NL190237C (nl) | Amino-ethers en geneesmiddel dat deze amino-ethers bevat. | |
NL182775C (nl) | Corticosteroide bevattende farmaceutische preparaten. | |
GB2038812B (en) | 1,2,4,5-tetra - alkyl - 4 - phenylpiperidines and pharmaceutical preparations thereof | |
DE2961804D1 (en) | N-(3-benzoylpropyl)-spiro-(dihydrobenzofuranpiperidines and -pyrrolidines), derivatives thereof, methods for their preparation and their use for medicines | |
NL191307C (nl) | Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten. | |
NL189041C (nl) | Werkwijze ter bereiding van optisch aktieve azabicyclohexanen alsmede werkwijze ter bereiding van een farmaceutisch preparaat. | |
NL7802069A (nl) | Pyrrolidinederivaten, werkwijze voor de berei- ding daarvan en dergelijke pyrrolidinederivaten bevattende geneesmiddelen. | |
NL187397C (nl) | Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding. | |
NL7903769A (nl) | Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan. | |
ATE10094T1 (de) | 3,4-bis-substituierte 1,2,5-oxadiazol-2-oxide, verfahren zu ihrer herstellung, und sie enthaltende pharmazeutische zubereitungen. | |
NL187239C (nl) | N-gesubstitueerd 2-cyaanaziridinederivaat, werkwijze voor het bereiden daarvan en farmaceutisch preparaat dat een dergelijk preparaat bevat. | |
NL7802380A (nl) | Benzylpyrimidinen, een werkwijze voor de berei- ding daarvan en farmaceutische preparaten die deze verbindingen bevatten. | |
NL7705561A (nl) | Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan. | |
IT8019430A0 (it) | Formulazione farmaceutica a cessione protratta. | |
DZ276A1 (fr) | Préparations pharmaceutiques. | |
NL7902268A (nl) | 2-hydroxymethylpyrazine-derivaten en een werkwijze voor de bereiding daarvan. | |
NL190120C (nl) | 2,3-dihydro-4h-1-benzopyran-4-on-0-carbamoyloximen alsmede farmaceutisch preparaat daarvan. | |
NL177214C (nl) | Geneeskrachtige preparaten met antimycotische eigenschappen, die 2,4-dichloorfenylimidazolylverbindingen bevatten, alsmede geneeskrachtige verbindingen geschikt voor gebruik in deze preparaten. | |
NL182641C (nl) | 3-amino-5-(4-pyridyl)-1,2,4-triazoolderivaten en deze derivaten bevattende farmaceutische preparaten. | |
NL184896C (nl) | Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten. | |
NL7714300A (nl) | Werkwijze voor de bereiding van benzoylfenoxya- zijnzuurderivaten en de toepassing hiervan in een farmaceutisch preparaat. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1A | A request for search or an international-type search has been filed | ||
BB | A search report has been drawn up | ||
A85 | Still pending on 85-01-01 | ||
CNR | Transfer of rights (patent application after its laying open for public inspection) |
Free format text: CONTINENTAL PHARMA, INC. |
|
BC | A request for examination has been filed | ||
V4 | Discontinued because of reaching the maximum lifetime of a patent |
Free format text: 20000324 |